Published in Am J Clin Pathol on December 01, 2001
Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2006) 2.12
Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature. J Cancer Res Clin Oncol (2004) 1.75
Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retin Eye Res (2010) 1.33
Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma. World J Gastroenterol (2005) 1.26
Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives. J Cancer Res Clin Oncol (2004) 1.12
Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches. Ann Surg (2003) 1.11
Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning. Cytokine Growth Factor Rev (2013) 1.05
Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma. J Gastroenterol (2007) 1.01
Formation of VEGF isoform-specific spatial distributions governing angiogenesis: computational analysis. BMC Syst Biol (2011) 0.94
Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways. J Biol Chem (2011) 0.93
Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma. J Clin Pathol (2004) 0.92
Development of sunitinib in hepatocellular carcinoma: rationale, early clinical experience, and correlative studies. Cancer J (2009) 0.88
Hepatocellular carcinoma: perfusion quantification with dynamic contrast-enhanced MRI. AJR Am J Roentgenol (2013) 0.88
Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization. World J Gastroenterol (2004) 0.87
Double contrast-enhanced two-dimensional and three-dimensional ultrasonography for evaluation of gastric lesions. World J Gastroenterol (2012) 0.86
Microvessel density and clinicopathologic characteristics in hepatocellular carcinoma with and without cirrhosis. Biomark Insights (2007) 0.86
Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts. J Cancer Res Clin Oncol (2003) 0.85
Identification and characterization of a novel small-molecule inhibitor of β-catenin signaling. Am J Pathol (2014) 0.85
Angiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration. Hepatol Int (2010) 0.84
Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future. Oncotarget (2010) 0.84
HIV-1 Tat mimetic of VEGF correlates with increased microvessels density in AIDS-related diffuse large B-cell and Burkitt lymphomas. J Hematop (2008) 0.84
Construction and clinical significance of a predictive system for prognosis of hepatocellular carcinoma. World J Gastroenterol (2005) 0.84
High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection. J Cancer Res Clin Oncol (2009) 0.84
Prognostic roles of cross-talk between peritumoral hepatocytes and stromal cells in hepatocellular carcinoma involving peritumoral VEGF-C, VEGFR-1 and VEGFR-3. PLoS One (2013) 0.82
Targeted therapy in hepatocellular carcinoma. Int J Hepatol (2011) 0.82
Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma. Int J Clin Oncol (2006) 0.82
Inflammatory response of endothelial cells to hepatitis C virus recombinant envelope glycoprotein 2 protein exposure. Mem Inst Oswaldo Cruz (2014) 0.80
Inhibition of hepatocellular carcinoma growth and angiogenesis by dual silencing of NET-1 and VEGF. J Mol Histol (2013) 0.80
Relationship between microvessel density and telomerase activity in hepatocellular carcinoma. World J Gastroenterol (2004) 0.80
Anti-hepatoma effect of arsenic trioxide on experimental liver cancer induced by 2-acetamidofluorene in rats. World J Gastroenterol (2005) 0.79
Deletion of the FHL2 gene attenuating neovascularization after corneal injury. Invest Ophthalmol Vis Sci (2008) 0.79
Analysis of p53 and vascular endothelial growth factor expression in human gallbladder carcinoma for the determination of tumor vascularity. World J Gastroenterol (2006) 0.79
VEGFR-1 activation-induced MMP-9-dependent invasion in hepatocellular carcinoma. Future Oncol (2015) 0.78
Functional expression of a proliferation-related ligand in hepatocellular carcinoma and its implications for neovascularization. World J Gastroenterol (2005) 0.78
Correlation of P-glycoprotein expression with poor vascularization in human gallbladder carcinomas. World J Gastroenterol (2003) 0.78
Antitumor and antiangiogenic activities of anti-vascular endothelial growth factor hairpin ribozyme in human hepatocellular carcinoma cell cultures and xenografts. World J Gastroenterol (2007) 0.76
Transarterial chemoembolization with/without cryotherapy is associated with improved clinical outcomes of sorafenib for the treatment of advanced hepatocellular carcinoma. Exp Ther Med (2012) 0.76
Targeting metastatic upper gastrointestinal adenocarcinomas. World J Clin Oncol (2011) 0.75
Anti‑angiogenic therapy for normalization of tumor vasculature: A potential effect of Buyang Huanwu decoction on nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential. Mol Med Rep (2016) 0.75
Downregulation of Vascular Endothelial Growth Factor Enhances Chemosensitivity by Induction of Apoptosis in Hepatocellular Carcinoma Cells. Cell J (2015) 0.75
Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells. Oncotarget (2017) 0.75
Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma. BMC Cancer (2016) 0.75
FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science (1998) 5.29
Effects of a decision support system on the diagnostic accuracy of users: a preliminary report. J Am Med Inform Assoc (1997) 4.61
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg (2000) 4.44
Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med (1992) 4.29
Two distinct mechanisms for long-range patterning by Decapentaplegic in the Drosophila wing. Nature (1996) 3.81
Isolation of the human insulin-like growth factor I gene using a single synthetic DNA probe. EMBO J (1984) 3.74
High-density microarray-mediated gene expression profiling of Escherichia coli. J Bacteriol (2001) 3.45
Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg (1998) 3.43
Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity (2000) 3.29
Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg (2001) 3.25
Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer (2000) 3.23
Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg (1999) 3.05
Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg (1995) 3.04
Anterior approach for difficult major right hepatectomy. World J Surg (1996) 2.94
Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg (1997) 2.83
Locus-specific variation in phosphorylation state of RNA polymerase II in vivo: correlations with gene activity and transcript processing. Genes Dev (1993) 2.82
Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem (1997) 2.73
Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J (2000) 2.48
Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol (1999) 2.47
Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg (1997) 2.44
The C-terminal repeat domain of RNA polymerase II largest subunit is essential in vivo but is not required for accurate transcription initiation in vitro. Proc Natl Acad Sci U S A (1988) 2.39
A study of factors influencing the rural location of health professionals. J Med Educ (1977) 2.33
Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem (1998) 2.32
Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest (1994) 2.31
Self-reported physician practices for children with asthma: are national guidelines followed? Pediatrics (2000) 2.31
Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg (1994) 2.22
beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer (2001) 2.17
A gene expression profile of Alzheimer's disease. DNA Cell Biol (2001) 2.16
p53 regulates a G2 checkpoint through cyclin B1. Proc Natl Acad Sci U S A (1999) 2.16
Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol (2001) 2.15
The yeast carboxyl-terminal repeat domain kinase CTDK-I is a divergent cyclin-cyclin-dependent kinase complex. Mol Cell Biol (1995) 2.14
Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg (2003) 2.10
Observations on the effect of movement on bone ingrowth into porous-surfaced implants. Clin Orthop Relat Res (1986) 2.08
Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng. Cancer Lett (2000) 2.02
The clinical significance of routine histopathologic study of the resected appendix and safety of appendiceal inversion. Surg Gynecol Obstet (1986) 2.02
Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg (2000) 2.01
Surgical lateral clearance in resected rectal carcinomas. A multivariate analysis of clinicopathologic features. Cancer (1993) 1.99
Anatomical collateral ligament reconstruction in the hand using intraosseous suture anchors and a free tendon graft. J Hand Surg Eur Vol (2012) 1.98
Pancreatic solid-cystic-papillary tumor: clinicopathologic features in eight patients from Hong Kong and review of the literature. World J Surg (1999) 1.98
Japanese encephalitis in north Queensland, Australia, 1998. Med J Aust (1999) 1.96
Emergency surgery for obstructing colorectal cancers: a comparison between right-sided and left-sided lesions. J Am Coll Surg (2001) 1.96
Management of spontaneous rupture of hepatocellular carcinoma: single-center experience. J Clin Oncol (2001) 1.93
Early versus delayed laparoscopic cholecystectomy for treatment of acute cholecystitis. Ann Surg (1996) 1.92
The bacteriology and septic complication of patients with appendicitis. Ann Surg (1984) 1.89
Experience with vesicoureteral reflux in children: clinical characteristics. J Urol (1997) 1.87
Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg (1997) 1.86
RBP1 recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma family proteins. Mol Cell Biol (1999) 1.86
Effects of a gastrin-like pentapeptide (I.C.I. 50,123) on stomach and pancreas. Lancet (1966) 1.85
Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana. Nature (2000) 1.85
Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg (2000) 1.83
Identification and characterization of a novel human aldose reductase-like gene. J Biol Chem (1998) 1.82
Global impact of sdiA amplification revealed by comprehensive gene expression profiling of Escherichia coli. J Bacteriol (2001) 1.78
Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study. Am J Gastroenterol (2000) 1.73
Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival. Arch Surg (1999) 1.68
Spontaneous rupture of hepatocellular carcinoma. Br J Surg (1996) 1.68
Global expression profiling of yeast treated with an inhibitor of amino acid biosynthesis, sulfometuron methyl. Physiol Genomics (2000) 1.67
The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol Psychiatry (2006) 1.64
Surgical treatment for pulmonary aspergilloma: a 28 year experience. Thorax (1997) 1.63
Biliary complications after hepatic resection: risk factors, management, and outcome. Arch Surg (1998) 1.63
Bleeding peptic ulcer: a prospective evaluation of risk factors for rebleeding and mortality. World J Surg (1990) 1.63
Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol (2000) 1.62
An analysis using DNA microarray of the time course of gene expression during syncytialization of a human placental cell line (BeWo). Placenta (2004) 1.62
Effect of remifentanil on oculocardiac reflex in paediatric strabismus surgery. Acta Anaesthesiol Scand (2008) 1.61
Cisplatin-based chemotherapy for ovarian germ cell malignancies: the Australian experience. J Clin Oncol (1994) 1.59
Pharmacological drug treatment of Alzheimer disease: the cholinergic hypothesis revisited. J Neuropathol Exp Neurol (1998) 1.57
TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses. Immunity (1999) 1.56
Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg (2007) 1.56
Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg (1998) 1.54
Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg (2001) 1.52
The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. J Neurosci (2000) 1.51
Reducing calcium overload in the ischemic brain. N Engl J Med (1999) 1.50
Thyroxine suppressive therapy of benign solitary thyroid nodules: a prospective randomized study. World J Surg (1990) 1.49
Intestinal inflammation and impact on growth in children with cystic fibrosis. J Pediatr Gastroenterol Nutr (2015) 1.47
Effects of prognosis, perceived benefit, and decision style on decision making and critical care on decision making in critical care. Crit Care Med (1999) 1.46
Oculomotor nerve cavernous angioma in a patient with Roberts syndrome. Surg Neurol (1993) 1.46
MR imaging-histopathologic correlation of radiofrequency thermal ablation lesion in a rabbit liver model: observation during acute and chronic stages. Korean J Radiol (2001) 1.43
Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg (1998) 1.42
Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Can J Anaesth (2003) 1.42
Resection of phaeochromocytoma extending into the right atrium in a patient with multiple endocrine neoplasia type 2A. Hong Kong Med J (2005) 1.42
eEF1A2 activates Akt and stimulates Akt-dependent actin remodeling, invasion and migration. Oncogene (2006) 1.41
Scanning electron microscopy of Chilomastix mesnili (Wenyon 1910) Alexieieff, 1912. Parasitol Res (2000) 1.41
Use of esophagectomy to treat recurrent hyperplastic tissue obstruction caused by multiple metallic stent insertion for corrosive stricture. Endoscopy (2000) 1.41
Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol (2001) 1.41
AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene (2010) 1.40
Minimum graft size for successful living donor liver transplantation. Transplantation (1999) 1.39
The detection and treatment of early lung cancer. Ann Surg (1974) 1.39
Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors. J Virol (2001) 1.39
Pancreatic pleural effusion: an indication for emergency distal pancreatectomy and Roux-en-Y pancreatico-jejunostomy. J Pediatr Surg (1994) 1.38
Early decision for conversion of laparoscopic to open cholecystectomy for treatment of acute cholecystitis. Am J Surg (1997) 1.36
Resection for extrahepatic recurrence of hepatocellular carcinoma. Br J Surg (1994) 1.34
Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients. Cancer (1995) 1.33
Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics. Am J Respir Crit Care Med (2000) 1.32
The appearance of a second genotype of Japanese encephalitis virus in the Australasian region. Am J Trop Med Hyg (2001) 1.32